NG
IDXX icon

Novem Group’s Idexx Laboratories IDXX Stock Holding History

Novem Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
457
-59
-11% -$33.1K 0.02% 392
2026
Q1 		$290K Buy
516
+29
+6% +$18.6K 0.03% 357
2025
Q4 		$329K Sell
487
-1,705
-78% -$1.16M 0.04% 320
2025
Q3 		$1.4M Buy
2,192
+37
+2% +$22.5K 0.16% 112
2025
Q2 		$1.16M Sell
2,155
-591
-22% -$283K 0.15% 118
2025
Q1 		$1.15M Buy
2,746
+681
+33% +$296K 0.16% 109
2024
Q4 		$854K Buy
+2,065
New +$906K 0.12% 139

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Novem Group's IDXX Position: Q2 2026 in Review

Novem Group reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $33.1K and leaving 457 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #392.

Novem Group first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.4M in Q3 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Novem Group held 457 shares of Idexx Laboratories worth $241K as of Q2 2026.
  • Novem Group sold 59 Idexx Laboratories shares in Q2 2026, an estimated $33.1K.
  • Idexx Laboratories made up 0.02% of Novem Group's portfolio in Q2 2026, its #392 holding.
  • Novem Group first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Idexx Laboratories position peaked at $1.4M in Q3 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.